Literature DB >> 2817247

Estrogen receptor in normal and neoplastic human thyroid tissue.

P K Chaudhuri1, R Prinz.   

Abstract

Clinical evidence suggests the possible influence of estrogen on the biologic behavior of thyroid neoplasm. In this study we evaluated the distribution and characteristics of intracellular receptors for estrogen in normal and neoplastic thyroid tissue obtained from 54 patients. Forty-two percent of all specimens assayed by the protamine sulfate precipitation technique had a detectable intracellular binding site for estrogen. Differentiated carcinomas (eight of eight) and adenomas (seven of nine) had high incidences of receptors compared with goiter (five of 23) and normal thyroid (three of eight). However, there were no detectable receptors for estrogen in medullary carcinomas of the thyroid (0 of six). Also, carcinomas and adenomas had higher receptor contents than did goiter and normal differentiated thyroid tissue. There was no significant difference in the affinity of estrogen for receptors among the different histologic groups. There were both 4S and 8S receptor types, which were specific for estrogen. The binding of estrogen to thyroid tissue and differentiated neoplasm originating from thyroid tissue were comparable to the binding of estrogen to other hormone-dependent normal and neoplastic tissues.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2817247     DOI: 10.1016/0196-0709(89)90107-5

Source DB:  PubMed          Journal:  Am J Otolaryngol        ISSN: 0196-0709            Impact factor:   1.808


  9 in total

1.  Increased risk of papillary thyroid cancer related to hormonal factors in women.

Authors:  Ping Wang; Long Lv; Feng Qi; Feng Qiu
Journal:  Tumour Biol       Date:  2015-02-11

Review 2.  Use of fertility medications and cancer risk: a review and update.

Authors:  Lindsay Kroener; Daniel Dumesic; Zain Al-Safi
Journal:  Curr Opin Obstet Gynecol       Date:  2017-08       Impact factor: 1.927

3.  Cancer Risk in Women Treated with Fertility Drugs According to Parity Status-A Registry-based Cohort Study.

Authors:  Marte Myhre Reigstad; Ritsa Storeng; Tor Åge Myklebust; Nan Birgitte Oldereid; Anne Katerine Omland; Trude Eid Robsahm; Louise Annette Brinton; Siri Vangen; Kari Furu; Inger Kristin Larsen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-01-20       Impact factor: 4.254

4.  Nonradiation risk factors for thyroid cancer in the US Radiologic Technologists Study.

Authors:  Cari L Meinhold; Elaine Ron; Sara J Schonfeld; Bruce H Alexander; D Michal Freedman; Martha S Linet; Amy Berrington de González
Journal:  Am J Epidemiol       Date:  2009-11-30       Impact factor: 4.897

5.  Longchain serum fatty acids and risk of thyroid cancer: a population-based case-control study in Norway.

Authors:  J P Berg; E Glattre; T Haldorsen; A T Høstmark; I G Bay; A F Johansen; E Jellum
Journal:  Cancer Causes Control       Date:  1994-09       Impact factor: 2.506

6.  Estrogen and progesterone receptors in thyroid lesions.

Authors:  B R Jaklic; J Rushin; B C Ghosh
Journal:  Ann Surg Oncol       Date:  1995-09       Impact factor: 5.344

7.  Pediatric thyroid carcinoma incidence and temporal trends in the USA (1973-2007): race or shifting diagnostic paradigm?

Authors:  Laurens Holmes; Jobayer Hossain; Franklin Opara
Journal:  ISRN Oncol       Date:  2012-03-06

8.  Role of estrogen in thyroid function and growth regulation.

Authors:  Ana Paula Santin; Tania Weber Furlanetto
Journal:  J Thyroid Res       Date:  2011-05-04

Review 9.  Reproductive Factors but Not Hormonal Factors Associated with Thyroid Cancer Risk: A Systematic Review and Meta-Analysis.

Authors:  Yijuan Cao; Zengyan Wang; Juan Gu; Fangfang Hu; Yujuan Qi; Qianqian Yin; Qingqing Sun; Guotao Li; Bin Quan
Journal:  Biomed Res Int       Date:  2015-08-03       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.